—Õ°–òŠw
’˜@‘
1)
¼ŒûHŽi: ˆã—ÖòŠw. ‘æ5”Å, –x@—¹•½@ŠÄC, Š£@Œ«ˆê‚ç@•ÒW, œAì‘“X (2009).
2)
¼ŒûHŽi: ŽÀ–±ŽÀKŽ–‘OŠwK‚Ì‚½‚ß‚Ì’²ÜŠw, ŽÄ賟‚ç@ŠÄC, Œú“cKˆê˜Y‚ç@•ÒW, œAì‘“X (2009).
3)
¼ŒûHŽi: ƒVƒiƒŠƒIÇ—á‰ðÍ -ˆã—Â̌»ê‚Å¡c-, ‚ŽR@–¾@•ÒW, œAì‘“X (2009).
˜_@•¶
1)
Marie Nagai, Takahiro Fukamachi,
Masayuki Tsujimoto, Kenichiro Ogura, Akira Hiratsuka, Hisakazu Ohtani, Satoko
Hori, Yasufumi Sawada: Inhibitory effects of herbal extracts on the activity of
human sulfotransferase isoform sulfotransferase 1A3 (SULT1A3). Biol. Pharm. Bull., 32, 105-109
(2009).
2)
ú㌴»Žq, ŽRXŒ³”Ž, ’†‘º@”C, ¼ŒûHŽi, ‰œ–ì’BÆ, ’ƒ‰®Œ´Ø•äŽq, ŽO–ض–ç, “c‘ºF—Y, •½ˆä‚Ý‚Ç‚è, •Ð‰ª˜aŽO˜Y, ‰h“c•q”V: H“¹‚ª‚ñ‰»Šw•úŽËü—Ö@‚É‚¨‚¯‚é5-ƒtƒ‹ƒIƒƒEƒ‰ƒVƒ‹ŒŒŸ÷’†”Z“x‚Æ•›ì—p‚Æ‚Ì‘ŠŠÖ. TDMŒ¤‹†, 26, 7-13 (2009).
3)
Sayo
Horibe, Kohji Takara, Tetsuya Minegaki, Noriaki Ohnishi, Teruyoshi Yokoyama: Distribution
of ABCG2 (BCRP) and ABCC2 (MRP2) mRNAs in rat small intestine and liver. EXCLI Journal, 8, 12-19 (2009).
4)
•õŠ_“N–ç,
¬—Ñ@–r, V@NŒ›, –k“c“¿º, X“c‘Žq, ‹g‰ª–r“W, ’Ò@—²Žu, “n@‰ëŽ, •“¡r•F, £”ö@“O:
•ó’ËŽs—§•a‰@‚É‚¨‚¯‚é‰@“à»Üƒuƒ[Ž‰t‚Ì—Õ°Žg—pŒoŒ±. Ž¨•@‚Æ—Õ°, 55, 26-30 (2009).
5)
Jahye Kim, Hisakazu Ohtani, Masayuki
Tsujimoto, Yasufumi Sawada: Quantitative comparison of the convulsive activity
of combinations of twelve fluoroquinolones with five nonsteroidal anti-inflammatory
agents. Drug
Metab. Pharmacokinet., 24, 167-174 (2009).
6)
Fumiaki
Kitazawa, Toshio Abe, Kumi Ueda, Satoshi Murakami, Kohshi Nishiguchi, Kohji
Takara, Teruyoshi Yokoyama, Hikofumi Sugii: Relation of age with
myelosuppression induced by the CHOP regimen in patients with Non-Hodgkinfs
Lymphoma. Cancer Therapy, 7, 133-140 (2009).
7)
Masayuki Tsujimoto, Maya Horie, Hiroko Honda, Kohji
Takara, Kohshi Nishiguchi: The structure-activity correlation on the inhibitory
effects of flavonoids on cytochrome P450 3A activity. Biol. Pharm. Bull., 32, 671-676 (2009).
8)
Tsutomu
Nakamura, Noboru Okamura, Mariko Yagi, Hideki Omatsu, Motohiro Yamamori, Akiko
Kuwahara, Kohshi Nishiguchi, Masanori Horinouchi, Katsuhiko Okumura, Toshiyuki
Sakaeda: Effects of ABCB1 3435C>T genotype on serum levels of cortisol and
aldosterone in women with normal menstrual cycles. Genet. Mol. Res., 8, 397-403 (2009).
9)
Kyohei
Shintaku, Satoko Hori, Masayuki Tsujimoto, Hideaki Nagata, Shoji Satoh, Kiyomi
Tsukimori, Hitoo Nakano, Tomoyuki Fujii, Yuji Taketani, Hisakazu Ohtani,
Yasufumi Sawada: Transplacental pharmacokinetics of diclofenac in perfused
human placenta. Drug Metab. Dispos., 37, 962-968 (2009).
10) Kohji Takara, Noriaki Kitada, Eri
Yoshikawa, Kazuhiro Yamamoto, Sayo Horibe, Toshiyuki Sakaeda, Kohshi
Nishiguchi, Noriaki Ohnishi, Teruyoshi Yokoyama: Molecular changes to HeLa
cells on continuous exposure to SN-38, an active metabolite of irinotecan
hydrochloride. Cancer Lett., 278, 88-96 (2009).
11) Akiko Kuwahara, Motohiro Yamamori, Kohshi
Nishiguchi, Tatsuya Okuno, Naoko Chayahara, Ikuya Miki, Takao Tamura, Tsubasa
Inokuma, Yoshiji Takemoto, Tsutomu Nakamura, Kazusaburo Kataoka, Toshiyuki
Sakaeda: Replacement of cisplatin with nedaplatin in a definitive
5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with
esophageal squamous cell carcinoma. Int.
J. Med. Sci., 6, 305-311 (2009).
12) –k“c“¿º, ¼–ì‰ës, ˆÀ“c@, X“c‘Žq, “¡ˆäç‰ê, •õŠ_“N–ç, ‹ß“¡–œ—F”ü, ˆ¢“ìߎq, ‚—ÇPŽj, “n@‰ëŽ: ˆê”Ê•a‰@‚É‚¨‚¯‚é“û‚ª‚ñ‰»Šw—Ö@‚Ì‹Ï‚Ä‚ñ‰»‚ð‚ß‚´‚µ‚Ä (‘æ2•ñj-FEC‚¨‚æ‚ÑTC—Ö@‚É‚¨‚¯‚éˆÀ‘S«‚ÌŒŸ“¢-. Šà‚Ɖ»Šw—Ö@, 36, 1671-1675 (2009).
‘@à
1)
Toshiyuki Sakaeda, Motohiro Yamamori,
Akiko Kuwahara, Kohshi Nishiguchi: Pharmacokinetics and pharmacogenomics in
esophageal cancer chemoradiotherapy. Adv.
Drug Deliv. Rev., 61,
388-401(2009).
Šw‰ï”•\“™
@@@Šw‰ï”•\
1)
“°‰º^—œ, ¬’r”ü, –å˜e—SŽq, ‰Ô–[‰Á“ÞŒb, ŒÜ•S‘ •Žm, ˜a“c@“Ö, ŠpŽRD, ê –{”Ž—Y, ¼ŒûHŽi, •½ˆä‚Ý‚Ç‚è: ˆÀ‘S‚ÈŠO—ˆ‰»Šw—Ö@‚É‚¨‚¯‚é–òÜŽt‚Ì–ðŠ„‚É‚Â‚¢‚Ä, ‘æ30‰ñ“ú–{•a‰@–òÜŽt‰ï@‹ß‹EŠwp‘å‰ï (‘åã), 2009. 1. 24-25.
2)
a’J“Þ•ä, …“c’¼”ü, A“c‹MŽj, ‘å¼G–¾, ŽR‰º˜a•F, ŠpŽRD, ê –{”Ž—Y, ¼ŒûHŽi, •½ˆä‚Ý‚Ç‚è, rì‘nˆê, Šâ“cŒ’‘¾˜Y: Žèp•”ƒTƒeƒ‰ƒCƒg–ò‹Ç‚̉^—p‚ÆŽèp’†‚ÌR‹Û–òŽg—p•û–@‚Ì“K³‰», ‘æ30‰ñ“ú–{•a‰@–òÜŽt‰ï@‹ß‹EŠwp‘å‰ï (‘åã), 2009. 1. 24-25.
3)
¬–ì—R‰Á—¢, A“c‹MŽj, “c’†Œ’‘¾, ŽRXŒ³”Ž, Šp–{Š²•v, ŠpŽRD, ê –{”Ž—Y, ¼ŒûHŽi, •½ˆä‚Ý‚Ç‚è: ƒ^ƒNƒƒŠƒ€ƒXŒŒ’†”Z“x‘ª’è‚É‚¨‚¯‚éACMIA–@‚ÆMEIA–@‚Ì”äŠr, ‘æ30‰ñ“ú–{•a‰@–òÜŽt‰ï@‹ß‹EŠwp‘å‰ï (‘åã), 2009. 1. 24-25.
4)
A“c‹MŽj, Šp–{Š²•v, ŽRXŒ³”Ž, ŠpŽRD, ê –{”Ž—Y, ¼ŒûHŽi, •½ˆä‚Ý‚Ç‚è: tˆÚAŠ³ŽÒ‚É‚¨‚¯‚éƒ^ƒNƒƒŠƒ€ƒX‚ƃvƒƒgƒ“ƒ|ƒ“ƒv‘jŠQÜ‚Ì–ò•¨‘ŠŒÝì—p, ‘æ30‰ñ“ú–{•a‰@–òÜŽt‰ï@‹ß‹EŠwp‘å‰ï (‘åã), 2009. 1. 24-25.
5)
ŠÛŽR“Þ•ä, ŠpŽRD, Šp–{Š²•v, ê –{”Ž—Y, ¼ŒûHŽi, •½ˆä‚Ý‚Ç‚è: ƒwƒpƒŠƒ“‹Nˆö«ŒŒ¬”ÂŒ¸Ç(HIT)‚ÉŠÖ‚·‚éˆã—Ã]Ž–ŽÒ‚Ì”FŽ¯“x’²¸, “ú–{–òŠw‰ï‘æ129”N‰ï (‹ž“s), 2009. 3. 26-28.
6)
ã“cC•½, 웽´, ‘Œ©‹±Žq, ‘º“c¬”Í, –؉ºŒ’Ži, ‹g“c–¾O, Šp–{Š²•v, ¼ŒûHŽi, •½ˆä‚Ý‚Ç‚è: ƒƒ‹ƒtƒ@ƒŠƒ“ŽŠ“K“Š—^—ÊŒˆ’è‚É‚¨‚¯‚éASP-PCR–@‚ð—p‚¢‚½ˆâ“`ŽqŒ^”»’è‚Ì—L—p«, “ú–{–òŠw‰ï‘æ129”N‰ï (‹ž“s), 2009. 3. 26-28.
7)
ŽR–{˜aG, Œ´@Œ«‘¾, ‰i“c³’j, ‚—ÇPŽj, ¼ŒûHŽi, •½ˆä‚Ý‚Ç‚è, ‰¡–ì_ˆê: ƒ‰ƒpƒ}ƒCƒVƒ“•W“Iƒ^ƒ“ƒpƒNŽ¿(mTOR)ƒVƒOƒiƒ‹“`’BŒn‚̉h—{Š´’mƒVƒXƒeƒ€‚Æ‚µ‚Ä‚Ì–ðŠ„‚Æ‚»‚Ì•ªŽqƒƒJƒjƒYƒ€, “ú–{–òŠw‰ï‘æ129”N‰ï (‹ž“s), 2009. 3. 26-28.
8)
–{“chŽq, ’Ò–{‰ë”V, ¬ì”ü•äŽq, ‘“c‰À‘ãŽq, ‰ª–{ŠG—¢, ¬–ì¹K, ‚—ÇPŽj, ¼ŒûHŽi: –ò•¨‚ÌÁ‰»ŠÇ–Œ“§‰ß«‚É‹y‚Ú‚·ŠeŽíˆù—¿Ž‘±”˜˜I‚̉e‹¿, “ú–{–òŠw‰ï‘æ129”N‰ï (‹ž“s), 2009. 3. 26-28.
9)
’Ò–{‰ë”V: “§ÍŠ³ŽÒ‚É‚¨‚¯‚étŠOƒNƒŠƒAƒ‰ƒ“ƒX‚Ì•Ï“®GƒVƒ“ƒ|ƒWƒEƒ€13u“§Í‚É‚¨‚¯‚é–ò•¨“Š—^‚Ì–â‘è“_vC‘æ54‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (‰¡•l)C2009. 6. 5-7.
10)
‰¡“clŽm, ’Ò–{‰ë”V, ”µ›½‘å‰î, ´…–ƒ—Œb, ŽR–{_Žj, ™–{ŽÑ—œ, ’·—F–ƒ‹KŽq, •õŠ_“N–ç, ‚—ÇPŽj, ¼ŒûHŽi: –«t•s‘Sƒ‚ƒfƒ‹ƒ‰ƒbƒg‚É‚¨‚¯‚é–ò•¨ƒgƒ‰ƒ“ƒXƒ|[ƒ^[‚Ì‘gD“ÁˆÙ“I‚È”Œ»•Ï“®, ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2009^‘æ17‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€ (‹ž“s) C2009. 7. 11-12.
11)
–{“chŽq, ’Ò–{‰ë”V, ‘“c‰À‘ãŽq, ¬ì”ü•äŽq, ‰ª–{ŠG—¢, ‚—ÇPŽj, ¼ŒûHŽi: Á‰»ŠÇ‚É‚¨‚¯‚é–ò•¨ƒgƒ‰ƒ“ƒXƒ|[ƒ^[‚É‹y‚Ú‚·ƒtƒ‰ƒ{ƒmƒCƒhŠÜ—Lˆù—¿‚ÌŽ‘±”˜˜I‚̉e‹¿, ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2009^‘æ17‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€ (‹ž“s), 2009. 7. 11-12.
12)
‰¡“clŽm, ’Ò–{‰ë”V, ™–{ŽÑ—œ, ’·—F–ƒ‹KŽq, •õŠ_“N–ç, ¼ŒûHŽi: t•s‘SisˆöŽq‚Å‚ ‚éƒCƒ“ƒhƒLƒVƒ‹—°Ž_‚ÌÁ‰»ŠÇ“®‘Ԃ̉ð–¾, ‘æ3‰ñ“ú–{t‚Æ–òÜŒ¤‹†‰ïŠwp‘å‰ï2009 (–¼ŒÃ‰®), 2009. 9. 19-20.
13)
åM“c’¼Šó, ‚—ÇPŽj, •õŠ_“N–ç, –k“c“¿º, ’Ò–{‰ë”V, ¼ŒûHŽi, ‰¡ŽRÆ—R: –Ô—…“Iˆâ“`Žq”Œ»‰ðÍ‚ÉŠî‚¢‚½RŽîᇫ”’‹àö‘ÌŠ´Žó«ˆöŽq‚Ì’Tõ, ‘æ19‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ï (’·è), 2009. 10. 24-25.
14)
Hiroko Honda, Masayuki Tsujimoto, Erika
Okamoto, Tetsuya Minegaki, Kohshi Nishiguchi: Effects of continuous ingestion
of grapefruit juice on the intestinal absorption of fexofenadine in mice, 24th
JSSX Annual Meeting in Kyoto, 2009. 11. 27-29.
15)
Daisuke Shima, Masayuki Tsujimoto, Shima
Hiraoka, Ayaka Miyoshi, Tetsuya Minegaki, Kohshi Nishiguchi: Mechanism for
decreased digoxin concentration by fexofenadine in hemodialysis patients, 24th
JSSX Annual Meeting in Kyoto, 2009. 11. 27-29.
@@@u‰‰“™
1)
¼ŒûHŽi: ‹ž“s–ò‰È‘åŠwƒI[ƒvƒ“ƒLƒƒƒ“ƒpƒX, ƒ~ƒju‹` (‹ž“s), 2009. 8.
2)
¼ŒûHŽi: _ŒË–ò‰È‘åŠw‘åŠw‰@u‹`, ƒtƒ@[ƒ}ƒVƒ…[ƒeƒBƒJƒ‹ƒPƒA“Á˜_ (_ŒË), 2009.
11.
3)
¼ŒûHŽi, ’Ò–{‰ë”V, •õŠ_“N–ç: ‹ž“s–ò‰È‘åŠwˆê”ÊŒöŠJuÀ, ƒ|ƒXƒ^[ŒfŽ¦ (‹ž“s), 2009. 11.
@@@‚»‚Ì‘¼
1)
¼ŒûHŽi: ŽQ‰Á. ‹ž“s–ò‰È‘åŠwE‹ž“s•{•a‰@–òÜŽt‰ï@˜AŒgƒ[ƒNƒVƒ‡ƒbƒv (‹ž“s), 2009. 1.
2)
¼ŒûHŽi: ŽQ‰Á. ‹ž“s•{–òÜŽt‰ïE‹ž“s•{•a‰@–òÜŽt‰ï@ŽÀ–±ŽÀKŽó“ü˜A—‰ï (‹ž“s), 2009. 8.
3)
¼ŒûHŽi: ˆÏˆõ, ‰Û‘èÓ”CŽÒ, ‘Š‡. ‹ž“s–ò‰È‘åŠw@–òŠw‹¤—pŽŽŒ±OSCE (‹ž“s), 2009. 12.
4)
’Ò–{‰ë”V: ‰Û‘èÓ”CŽÒ. ‹ž“s–ò‰È‘åŠw@–òŠw‹¤—pŽŽŒ±OSCE (‹ž“s), 2009. 12.
5)
•õŠ_“N–ç: ƒXƒ^ƒbƒtƒ`[ƒt. ‹ž“s–ò‰È‘åŠw@–òŠw‹¤—pŽŽŒ±OSCE (‹ž“s), 2009. 12.
6)
¼ŒûHŽi, ’Ò–{‰ë”V, •õŠ_“N–ç: •]‰¿ŽÒ. “¯ŽuŽÐ—Žq‘åŠw@–òŠw‹¤—pŽŽŒ±OSCE (‹ž“s), 2009. 12.